UroGen Pharma
URGN
URGN
112 hedge funds and large institutions have $407M invested in UroGen Pharma in 2024 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 31 increasing their positions, 36 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
8.79% more ownership
Funds ownership: 70.82% → 79.61% (+8.8%)
7% more funds holding
Funds holding: 105 → 112 (+7)
14% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 36
Holders
112
Holding in Top 10
2
Calls
$920K
Puts
$728K
Top Buyers
| 1 | +$24.4M | |
| 2 | +$23M | |
| 3 | +$19.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14.8M |
| 5 |
JFG
Jefferies Financial Group
New York
|
+$12.6M |
Top Sellers
| 1 | -$7.8M | |
| 2 | -$5.77M | |
| 3 | -$2.95M | |
| 4 |
Renaissance Technologies
New York
|
-$1.37M |
| 5 |
Cerity Partners
New York
|
-$1.32M |